#Cholangiocarcinoma Market
Explore tagged Tumblr posts
Visit Tumblr Blog
Explore Tumblr blogs with no restrictions, modern design and the best experience.
Last Seen Tumblr Blogs
Fun Fact
Tumblr.com is the 103rd most visited website in the world.
Text
https://social.studentb.eu/read-blog/178810_cholangiocarcinoma-market-share-overview-competitive-analysis-and-forecast-2031.html
The Cholangiocarcinoma Market in 2023 is US$ 236.82 million, and is expected to reach US$ 630.46 million by 2031 at a CAGR of 13.00%.
0 notes
Text
Global Cholangiocarcinoma Market Is Estimated To Witness High Growth Owing To Rising Incidences of the Disease
The global Cholangiocarcinoma Market is estimated to be valued at US$ 185.4 million in 2021 and is expected to exhibit a CAGR of 12.8% over the forecast period 2021-2028, as highlighted in the new report published by Coherent Market Insights. Cholangiocarcinoma, also known as bile duct cancer, is a rare and aggressive form of cancer that affects the bile ducts. The market for Cholangiocarcinoma is driven by the increasing incidences of the disease and the need for effective treatment options. Market Overview: Cholangiocarcinoma is a deadly cancer that arises from the cells lining the bile ducts, which are responsible for carrying bile from the liver to the small intestine. This cancer is difficult to diagnose in its early stages and is often detected at an advanced stage when treatment options are limited. The market for Cholangiocarcinoma is driven by the need for targeted therapies and innovative treatment approaches to improve patient outcomes. Currently, there are limited treatment options available for patients with Cholangiocarcinoma, which creates a significant unmet need in the market. Market Key Trends: One key trend in the Cholangiocarcinoma Market is the increasing focus on precision medicine and targeted therapies. Precision medicine involves tailoring treatment plans based on an individual's genetic makeup, allowing for more personalized and effective treatments. Several pharmaceutical companies are investing in research and development to identify specific genetic mutations and biomarkers associated with Cholangiocarcinoma to develop targeted therapies. For example, Incyte Corporation and QED Therapeutics are conducting clinical trials for their targeted therapy, pemigatinib, which has shown promising results in patients with locally advanced or metastatic Cholangiocarcinoma. PEST Analysis: - Political: Government initiatives and regulations play a crucial role in the development and availability of treatments for Cholangiocarcinoma. Governments are increasingly focusing on improving cancer care and funding research programs. - Economic: The economic impact of Cholangiocarcinoma is significant, as it requires long-term treatment and care. The high cost of treatment options and supportive care pose challenges for patients and healthcare systems. - Social: The increasing awareness about Cholangiocarcinoma among the general population and healthcare professionals is driving early detection and diagnosis. Support groups and patient advocacy organizations are providing support and resources to patients and their families. - Technological: Advances in diagnostic technologies, such as molecular testing and imaging techniques, are enabling early detection and accurate diagnosis of Cholangiocarcinoma. Additionally, the development of targeted therapies and immunotherapies is revolutionizing the treatment landscape for this aggressive cancer. Key Takeaways: In terms of market size, the global Cholangiocarcinoma market is expected to witness high growth, exhibiting a CAGR of 12.8% over the forecast period, due to increasing incidences of the disease. The rising prevalence of risk factors such as primary sclerosing cholangitis (PSC), hepatitis B and C infections, and exposure to certain chemicals and toxins are contributing to the growing incidence of Cholangiocarcinoma. Moreover, the lack of effective treatment options for this aggressive cancer creates opportunities for pharmaceutical companies to develop innovative therapies to improve patient outcomes. Key players operating in the global Cholangiocarcinoma market are Incyte Corporation, Eisai Co., Ltd., QED Therapeutics, Inc., Agios Pharmaceuticals, Inc., RenovoRx, Ability Pharmaceuticals, Imbrium Therapeutics L.P., and Delcath Systems, Inc. These companies are focusing on strategic collaborations, clinical trials, and research and development activities to develop effective treatment options for Cholangiocarcinoma.
#Cholangiocarcinoma#Cholangiocarcinoma Market#Cholangiocarcinoma Market Size#Cholangiocarcinoma Market Demand#Cholangiocarcinoma Market Growth#Pharmaceutical
0 notes
Text
Holidays 2.15
Holidays
Angelman Syndrome Day
Annoy Squidward Day (SpongeBob Squarepants)
Battleship Day
Broken Hearts Day
Clifford the Big Red Dog Day
Commonwealth Day (Gibraltar)
Court of International Justice Day
Day of Ashakalia (Kosovo)
Day of the Mexican Woman (Mexico)
Decimal Day (UK)
Digital Learning Day
ENIAC Day (Philadelphia, Pennsylvania)
European Perioperative Nursing Day (EU)
First Connections Awareness Day (Rhode Island)
Galileo Day [also 2.29]
Hazel Day (French Republic)
Hazrat Alis Day (Uttar Pradesh, India)
International Angelman Day
International Bottom Appreciation Day
International Childhood Cancer Day
International Duties Memorial Day (Russia)
International Fanworks Day
International Green Wall Day
International Male Chastity Day
John Frum Day (Vanuatu)
Love Reset Day
Lui-Ngai-Ni (Manipur, India)
Memorial Day of Warriors—Intrnationalists
National Bad Breath Day
National Black Girl Magic Day
National Friendzone Day
National Plan B Day
National School Resource Officer Appreciation Day
National Side Chicks Day
National Wisconsin Day
Plastic Pollution Awareness Day (Georgia)
Remember the Maine Day
Sandlasting Day
Singles Awareness Day
Slap Day
Sretenje (Serbia)
Sticky Stamp Day
Stop and Smell Your Compost Pile Day
St. Skeletor’s Day
Susan B. Anthony Day
Total Defense Day (Singapore)
World Cholangiocarcinoma Day
YouTube Launch Day
Food & Drink Celebrations
Burger Lover's Day
Cherry Garcia Day
Florida Craft Beer Day
Mustard Day
National Cheap Chocolate Day
National Chewing Gum Day
National Gumdrop Day
National I Want Butterscotch Day
National Lamb Day (New Zealand)
Nature Celebrations
Cedar Day (I Live For You; Korean Birth Flowers)
World Hippo Day
Independence, Flag & Related Days
Barbettia (Declared; 2016) [unrecognized]
Dadingisila (Declared; 2010) [unrecognized]
Flag Day (Canada)
Liberation Day (Afghanistan)
Iustus (Declared; 2018) [unrecognized]
Serbia (from the Ottoman Empire, 1804)
St. Louis (Establishment Day; Missouri; 1764)
3rd Saturday in February
Barley Wine Day (San Francisco) [Saturday before Presidents Day]
Community Pubs Week begins (UK) [3rd Saturday through 4th Saturday]
International Restaurant Day [3rd Saturday] (also May, Aug & Nov)
National Black Movie Day [3rd Saturday]
Red Sock Day [3rd Saturday]
Sandwich Saturday [Every Saturday]
Sentimental Saturday [3rd Saturday of Each Month]
Six For Saturday [Every Saturday]
Spaghetti Saturday [Every Saturday]
Steak Saturday [3rd Saturday of Each Month]
World Pangolin Day [3rd Saturday]
World Whale Day [3rd Saturday]
Weekly Holidays beginning February 15 (2nd Week of February)
Hardee County Fair (Wauchula, Florida) [thru 2.22]
National FFA Week (thru 2.22) [Saturday to Saturday containing 2.22]
National Write Your Book in a Weekend Weekend
Omaha Beer Week (Omaha, Nebraska) [thru 2.23]
Real Bread Week (thru 2.23) [2nd to Last Saturday to Saturday]
Festivals On or Beginning February 15, 2025
Asian American Expo (La Verne, California) [thru 2.16]
Arizona Strong Beer Festival (Phoenix, Arizona)
Bay Area Renaissance Festival (Tampa, Florida) thru 3.30]
Bayou King Cake Festival (Thibodaux, Louisiana)
Carnival of Acireale (Acireale, Sicily, Italy) [thru 3.4]
Cedarburg Winter Festival (Cedarburg, Wisconsin) [thru 2.16]
Chinese New Year’s Parade (San Francisco, California)
Color the Wind Kite Festival (Clear Lake, Iowa)
Cortez Commercial Fishing Festival (Cortez, Florida) [thru 2.16]
Florida Keys Seafood Festival (Key West, Florida)) [thru 2.16]
International White Wine Festival in Anderson Valley (Boonville, California) [thru 2.16]
Jupiter Seafood Festival (Jupiter, Florida) [thru 2.16]
Melodifestivalen (Västeras, Sweden)
Menton Lemon Festival (Menton, France) [thru 3.2]
Nice Carnival (Nice, France) [thru 3.2]
NYS Ice Wine & Culinary Festival (Fairport, New York)
Palm Beach Marine Flea Market and Seafood Festival (West Palm Beach, Florida) [thru 2.16]
Takeuchi Festival (Rokugo, Japan)
Writers Guild Awards (Los Angeles, California)
3rd Thursday in February
Energy Saving Day (Italy) [3rd Thursday]
Global Information Governance Day [3rd Thursday]
National Conductive Education Day [3rd Thursday]
Switch Off Thursday (UK) [Thursday of Go Green Week]
Throwback Thursday [Every Thursday]
World Anthropology Day [3rd Thursday]
World Cholanglocarcinoma Day [3rd Thursday]
Weekly Holidays beginning February 15
American Association for the Advancement of Science Week [thru 2.17]
National Write Your Book in a Weekend Weekends [thru 2.18] (also in Apr, Sep & Nov)
Feast Days
Agape (Christian; Virgin Martyr)
Candlemas (Eastern Orthodox Church)
Chongwoldaeboreum (Korean Folk Festival)
Claude de la Colombière (Christian; Saint)
Drink More Wine Day (Pastafarian)
Faunus (celebrates animals helping humans)
Faustinus and Jovita (Christian; Martyrs)
Februata — Day of Juno Febuata (Pagan)
Festival of Naked Pan (Ancient Rome)
Festival of the Wolves (Starza Pagan Book of Days)
Grigori Rasputin Day (Church of the SubGenius)
Guardian Angel Day (Celtic Book of Days)
Kamakura Matsuri (Snow Cave Festival; Japan)
Lupercalia (Festival of Lupercus; Festival of purification honoring Lycaen Pan or Faunusl Ancient Roman god of flocks and fertility)
Michał Sopoćko (Christian; Blessed)
Nirvana Day (Buddhist; Jain; Sikh)
Oswiu (Christian; Saint)
Parinirvana Day (Mahayana Buddhism)
Phaedrus (Positivist; Saint)
Quinidius (Christian; Saint)
The Raggmopps (Muppetism)
Sarkis of Armenia (Christian; Saint)
Sigfried of Sweden (Christian; Saint)
Sigfrid’s Day
Tales of Kelp-Koli (Shamanism)
Tanco (a.k.a. Tatto; Christian; Martyr)
Thomas Bray (Anglican & Episcopal Church)
Walfrid (Christian; Saint)
Lunar Calendar Holidays
Chinese: Month 1 (Wu-Yin), Day 18 (Yi-Mao)
Day Pillar: Wood Rabbit
12-Day Officers/12 Gods: Remove Day (除 Chu) [Auspicious]
Holidays: None Known
Secular Saints Days
Susan B. Anthony (Politics)
Harold Arlen (Music)
John Barrymore (Entertainment)
Claire Bloom (Entertainment)
Norman Bridwell (Art)
Roger Chaffee (Astronaut)
Charles-François Daubigny (Art)
Galileo Galilei (Science)
Matt Groening (Art)
Douglas Hofstadter (Literature)
Harvey Korman (Entertainment)
Melissa Manchester (Music)
Sax Rohmer (Literature)
Jane Seymour (Entertainment)
Ernest Shackleton (Exploring)
Art Spiegelman (Art)
Charles-André van Loo (Art)
Alfred North Whitehead (Science)
Lucky & Unlucky Days
Shakku (赤口 Japan) [Bad luck all day, except at noon.]
Uncyclopedia Bad to Be Born Today (because so many reasons carrying on from the night before.)
Premieres
Alice’s Mysterious Mystery (Ub Iwerks Disney Cartoon; 1926)
Alice Solves the Puzzle (Ub Iwerks Disney Cartoon; 1925)
Alice’s Orphan (Disney Cartoon; 1930)
Angel and the Badman (Film; 1947)
Asterix: The Secret of the Magic Potion (Animated Film; 2019)
Autumn (Silly Symphony Disney Cartoon; 1930)
The Bears and the Bees (Disney Silly Symphony Cartoon; 1932)
The Blue Danube, by Johann Strauss II (Waltz; 1867)
The Breakfast Club (Film; 1985)
Blue Moon, recorded by The Marcels (Song; 1961)
Broad City (TV Series; 2010)
Bugs Bunny’s Wild World of Sports (WB Animated TV Special; 1989)
Burn, by Deep Purple (Album; 1974)
Burr Gore, by Vidal (Historical Novel; 1973)
Cinderella (Animated Disney Cartoon; 1950)
Clifford the Big Red Dog, by Norman Bridwell (Children’s Book; 1963)
Corregidora, by Gayl Jones (Novel; 1975)
Cowboy Blues (Aesop’s Sound Fable Cartoon; 1931)
The Crackpot Quail (WB MM Cartoon; 1941)
The Crystal Maze (UK TV game Show; 1990)
The Deep Boo Sea (Caspar Cartoon; 1952)
Doom Patrol (TV Series; 2019)
Eastbound & Down (TV Series; 2009)
Eight Days a Week, by The Beatles (Song; 1965)
Elegy Written in. A Country Churchyard, by Thomas Gray (Poem; 1751)
11.23.63 (TV Series; 2016)
Escape from Planet Earth (Animated Film; 2013)
Felix Crosses the Crooks (Felix the Cat Cartoon; 1927)
Felix the Cat Rests in Peace (Felix the Cat Cartoon; 1926)
Fly by Night, by Rush (Album; 1975)
Flying Yeast (Krazy Kat Cartoon; 1929)
Fun, Fun, Fun, by The Beach Boys (Song; 1964)
The Gay Anties (WB MM Cartoon; 1947)
Get Happy!!, by Elvis Costello (Album; 1980)
Glad All Over, by the Dave Clark Five (Song; 1964)
The Haunted Mouse (WB MM Cartoon; 1941)
The Heritage (Hearst-Pathe News Cartoon; 1918)
A Horse’s Tale (Sugarfoott Walter Lantz Cartoon; 1954)
Lifehouse, by The Who (Rock Opera; 1971)
Marlowe (Film; 2023)
Mechanical Man (Oswald the Lucky Rabbit Cartoon; 1932)
Orphan’s Picnic (Mickey Mouse Disney Cartoon; 1936)
Presidential One-Dollar Coin (U.S. Mint; 2007)
Professor Dabbler (Kriterion Kosmos Kartoons Cartoon; 1915)
Radio Riot (Fleischer Tarlkartoon Cartoon; 1930)
Red Dwarf (UK TV Series; 1988)
Return to Never Land (Disney Film; 2002)
Robin Hoody Woody (Woody Woodpecker Cartoon; 1963)
The Screwball (Woody Woodpecker Cartoon; 1943)
Shake, Rattle and Roll, recorded by Big Joe Turner (Song; 1954)
The Stars, Like Dust, byIsaac Asimov (Novel; 1951) [Galactic Empire #1]
Sucker Games (Krazy Kat Cartoon; 1926)
Super Troopers (Film; 2002)
Take the A Train, recorded by Duke Ellington (Song; 1941)
Taking the Blame (Betty Boop Cartoon; 1935)
A Tuba to Cuba (Documentary Film; 2019)
The Umbrella Academy (TV Series; 2019)
University of Nebraska (School; 1869)
Vision Quit (Film; 1985)
YouTube (Video Sharing Website; 2005)
Today’s Name Days
Georgia, Siegfried (Austria)
Faustin, Onezim, Vitomir (Croatia)
Jiřina (Czech Republic)
Faustinus (Denmark)
Neidi, Tiina (Estonia)
Sipi, Sippo (Finland)
Claude, Georgina, Jordan (France)
Georgia, Jovita, Siegfried (Germany)
Evsevios (Greece)
Julianna, Lilla (Hungary)
Giuliana (Italy)
Džuljeta, Juliāna, Jūlija, Smuidra (Latvia)
Julijona, Julijonas, Tautvydas (Lithuania)
Jill, Julian, Juliane (Norway)
Bernard, Dan, Danisz, Danuta, Julianna, Symeon (Poland)
Pamfil, Valentin (Romania)
Anna (Russia)
Ida (Slovakia)
Juliana (Spain)
Julia, Julius (Sweden)
Cliff, Clifford, Clifton, Jeremiah, Jeremy, Sonnie, Sonny, Sunny (USA)
Today’s National Name Days
National Clementine Day
National Marcus Day
Today is Also…
Day of Year: Day 46 of 2025; 319 days remaining in the year
ISO Week: Day 6 of Week 7 of 2025
Celtic Tree Calendar: Luis (Rowan) [Day 26 of 28]
Chinese: Month 1 (Wu-Yin), Day 18 (Yi-Mao)
Chinese Year of the: Snake 4723 (until February 17, 2026) [Ding-Chou]
Coptic: 8 Amshir 1741
Druid Tree Calendar: Hackberry (Feb 9-18) [Day 7 of 10]
Hebrew: 17 Shevat 5785
Islamic: 16 Sha’ban 1446
Julian: 2 February 2025
Moon: 91%: Waning Gibbous
Positivist: 18 Homer (2nd Month) [Phaedrus)
Runic Half Month: Sigel (Sun) [Day 10 of 15]
Season: Winter (Day 57 of 90)
SUn Calendar: 16 Gray; Twosday [16 of 30]
Week: 2nd Week of February
Zodiac:
Tropical (Typical) Zodiac: Aquarius (Day 27 of 30)
Sidereal Zodiac: Aquarius (Day 3 of 30)
Schmidt Zodiac: Capricorn (Day 21 of 27)
IAU Boundaries (Current) Zodiac: Capricorn (Day 27 of 28)
IAU Boundaries (1977) Zodiac: Capricornus (Day 28 of 28)
2 notes
·
View notes
Text
Fibroblast Growth Factor Receptor 2 Market Size, Key Players & Growth Challenges
Global Fibroblast Growth Factor Receptor 2 Market Overview The global FGFR2 market was valued at approximately USD 1.2 billion in 2023 and is projected to reach between USD 2.5–3.5 billion by 2031–2032, reflecting a robust CAGR of around 10–12.5% over the next 5–10 years. This growth trajectory is driven by key factors such as the rising incidence of cancers with FGFR2 mutations (e.g., urothelial, cholangiocarcinoma, gastric cancers), continued investment in precision oncology, and an expanding pipeline of targeted therapeutics including small molecule inhibitors, monoclonal antibodies, and gene therapies. Technological advancements in genomics, enhanced diagnostic assays, and increased government and private funding are also fueling market expansion. The Asia-Pacific region is expected to show the fastest growth, while North America and Europe maintain dominant market shares due to mature healthcare infrastructure and favorable reimbursement policies. Global Fibroblast Growth Factor Receptor 2 Market Dynamics Drivers: Rising cancer burden with FGFR2 alterations; unmet medical needs in advanced and rare cancers; accelerating approvals of next-generation FGFR2 inhibitors; expanding R&D in targeted therapeutics. Restraints: High cost of drug development, cost containment policies, and limited patient populations due to specific mutation-driven indication. Opportunities: Expansion into genetic disorders; development of companion diagnostics; regional growth in Asia-Pacific; combination therapies to overcome resistance. Role of technology: Precision medicine platforms, advances in genomic sequencing and biomarker-driven trials are central to growth. Regulations: Accelerated approval pathways support innovation, though stringent safety/efficacy criteria can delay commercialization. Sustainability: Biotech firms are optimizing manufacturing processes, scaling up biologics and gene therapy pipelines to reduce cost and environmental impact. Download Full PDF Sample Copy of Global Fibroblast Growth Factor Receptor 2 Market Report @ https://www.verifiedmarketresearch.com/download-sample?rid=441625&utm_source=PR-News&utm_medium=385 Global Fibroblast Growth Factor Receptor 2 Market Trends and Innovations Product innovation remains a prominent trend, led by allosteric inhibitors (e.g., alofanib), antibody–drug conjugates targeting FGFR2b, and irreversible kinase inhibitors like futibatinib. Collaborative alliances between pharmaceutical companies and academic centers are accelerating clinical development; multiple late-stage and Phase I–II trials are underway with novel FGFR2-targeting agents. Moreover, combination therapy strategies (targeted + immunotherapy) are gaining traction as a means to increase efficacy and delay resistance. Digital pathology, AI-driven biomarker discovery, and companion diagnostic assays are creating a more integrated precision oncology ecosystem. Manufacturing platforms for monoclonal antibodies and biosimilars are also evolving to reduce time‑to‑market. Global Fibroblast Growth Factor Receptor 2 Market Challenges and Solutions Challenges: High R&D costs, limited patient pools, supply chain constraints for specialty drugs, pricing pressures from payers, and complex regulatory hurdles. Additionally, adverse-effect profiles (e.g., hyperphosphatemia, ocular toxicity) pose adoption barriers. Solutions: Adaptive clinical trial designs (basket & umbrella trials) help recruit rare-mutation cohorts. Strategic partnerships for manufacturing scale-up and shared risk reduce cost burdens. Biosimilars and generics following patent expiry may lower prices. Health economics and outcomes research (HEOR) data support reimbursement negotiations, while digital engagement can improve patient monitoring and adverse-event management. Global Fibroblast Growth Factor Receptor 2 Market Future Outlook Over the next decade, the FGFR2 market will likely experience double-digit growth, driven by expanding treatment indications, enhanced diagnostics, and next‑gen therapeutic platforms (e.
g., gene editing, ADCs). Asia-Pacific will outpace mature regions in growth rate, with emerging economies rapidly adopting targeted oncology solutions. Biopharma investment in precision drug development will intensify, particularly around combination regimens and orphan/disease-specific indications. Regulatory regulators will increasingly adopt accelerated pathways. In addition, sustainability metrics and environmental impact of biologic manufacturing will become differentiators, leading to greener production methods. The convergence of digital health, AI diagnostics, and molecular therapy positions FGFR2 as a frontrunner in the personalized medicine renaissance. Key Players in the Global Fibroblast Growth Factor Receptor 2 Market Global Fibroblast Growth Factor Receptor 2 Market are renowned for their innovative approach, blending advanced technology with traditional expertise. Major players focus on high-quality production standards, often emphasizing sustainability and energy efficiency. These companies dominate both domestic and international markets through continuous product development, strategic partnerships, and cutting-edge research. Leading manufacturers prioritize consumer demands and evolving trends, ensuring compliance with regulatory standards. Their competitive edge is often maintained through robust R&D investments and a strong focus on exporting premium products globally. Novartis AG Eli Lilly and Company Johnson & Johnson Bristol-Myers Squibb AstraZeneca. Get Discount On The Purchase Of This Report @ https://www.verifiedmarketresearch.com/ask-for-discount?rid=441625&utm_source=PR-News&utm_medium=385 Global Fibroblast Growth Factor Receptor 2 Market Segments Analysis and Regional Economic Significance The Global Fibroblast Growth Factor Receptor 2 Market is segmented based on key parameters such as product type, application, end-user, and geography. Product segmentation highlights diverse offerings catering to specific industry needs, while application-based segmentation emphasizes varied usage across sectors. End-user segmentation identifies target industries driving demand, including healthcare, manufacturing, and consumer goods. These segments collectively offer valuable insights into market dynamics, enabling businesses to tailor strategies, enhance market positioning, and capitalize on emerging opportunities. The Global Fibroblast Growth Factor Receptor 2 Market showcases significant regional diversity, with key markets spread across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Each region contributes uniquely, driven by factors such as technological advancements, resource availability, regulatory frameworks, and consumer demand. By Drug Type By End-User By Therapy Type By Geography • North America• Europe• Asia Pacific• Latin America• Middle East and Africa For More Information or Query, Visit @ https://www.verifiedmarketresearch.com/product/fibroblast-growth-factor-receptor-2-market/ About Us: Verified Market Research Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions. Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research. Contact us: Mr. Edwyne Fernandes US: +1 (650)-781-4080 US Toll-Free: +1 (800)-782-1768 Website: https://www.verifiedmarketresearch.com/ Top Trending Reports https://www.verifiedmarketresearch.com/ko/product/dental-burs-market/
https://www.verifiedmarketresearch.com/ko/product/diabetic-ulcers-treatment-market/ https://www.verifiedmarketresearch.com/ko/product/photobiostimulation-devices-market/ https://www.verifiedmarketresearch.com/ko/product/postoperative-pain-management-market/ https://www.verifiedmarketresearch.com/ko/product/red-biotechnology-market/
0 notes
Text
Radiofrequency Ablation (RFA) Devices Market to Witness 9.37% CAGR Growth Between 2024 and 2030
According to a recent comprehensive by MarkNtel Advisors Radiofrequency Ablation (RFA) Devices Market research report, the Radiofrequency Ablation (RFA) Devices market is set for significant growth, driven by factors such as market size, share, and evolving trends.
This detailed report offers crucial insights into the market, covering key aspects such as market segmentation and definitions. It outlines the main drivers of growth and provides a clear forecast of the industry’s future direction. Additionally, the study provides a thorough overview of the competitive landscape, detailing recent developments and regional distribution across major areas. An expert competitor analysis delivers an in-depth understanding of market dynamics, offering strategic recommendations for businesses and investors.
✅In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.
With its robust analysis and forward-looking projections, this report is an essential resource for stakeholders aiming to leverage emerging opportunities and address potential challenges in the Radiofrequency Ablation (RFA) Devices market.
Get a Sample PDF of Report - https://www.marknteladvisors.com/query/request-sample/radiofrequency-ablation-devices-market.html
Radiofrequency Ablation (RFA) Devices Market (2024-2030): Analysis and Growth
The Global Radiofrequency Ablation (RFA) Devices Market is estimated to grow at a CAGR of around 9.37% during the forecast period, i.e., 2024-30
What are the key drivers fueling growth in the Radiofrequency Ablation (RFA) Devices market from 2024-2030?
Increasing Incidences of Gastrointestinal Diseases to Drive Market Growth – Globally, some of the important thing illnesses that RFA devices have these days include cholangiocarcinoma, esophageal squamous mobile dysplasia, and so forth. Therefore, due to their expanded prevalence, specifically throughout growing countries like Brazil, India, Mexico, etc., the demand for RFA gadgets has stepped forward. Also, the incidence of gastrointestinal infections has appreciably long gone up, and this has been fueling demand for much less invasive approaches along with RFA gadgets for functions of treatment.
Radiofrequency Ablation (RFA) Devices Market : Segmentation Analysis
-By Product Type
-Radiofrequency Generators- Market Size & Forecast 2019-2030, USD Million
-Consumables- Market Size & Forecast 2019-2030, USD Million
-Radiofrequency Electrodes- Market Size & Forecast 2019-2030, USD Million
-Radiofrequency Probes- Market Size & Forecast 2019-2030, USD Million
-Radiofrequency Catheters- Market Size & Forecast 2019-2030, USD Million
-Radiofrequency Cannulas- Market Size & Forecast 2019-2030, USD Million
-Others (RF Needles, Grounding Pads, etc.)- Market Size & Forecast 2019-2030, USD Million
-By Procedure Type
-Bipolar Radiofrequency Ablation- Market Size & Forecast 2019-2030, USD Million
-Unipolar Radiofrequency Ablation- Market Size & Forecast 2019-2030, USD Million
-Others (Pulsed RFA, Laser RFA, etc.) - Market Size & Forecast 2019-2030, USD Million
-By Application
-Cardiology- Market Size & Forecast 2019-2030, USD Million
-Oncology- Market Size & Forecast 2019-2030, USD Million
-Pain Management- Market Size & Forecast 2019-2030, USD Million
-Neurology- Market Size & Forecast 2019-2030, USD Million
-Others (Thyroid, Gynecological, etc.)- Market Size & Forecast 2019-2030, USD Million
-By End User
-Hospitals- Market Size & Forecast 2019-2030, USD Million
-Ambulatory Surgical Centers- Market Size & Forecast 2019-2030, USD Million
-Others (Specialty Clinics, Research Organizations, etc.)- Market Size & Forecast 2019-2030, USD Million
-By Region
-North America
-South America
-Europe
-The Middle East & Africa
-Asia-Pacific
Explore the Complete Analysis Report – https://www.marknteladvisors.com/research-library/radiofrequency-ablation-devices-market.html
What role do key competitors play in shaping the market, and how are they adapting to emerging trends and challenges?
Boston Scientific Corporation, Pajunk, Abbott, Medtronic, Stryker, BIOTRONIK Schweiz AG, AngioDynamics, CONMED Corporation, Lepu Medical Technology(Beijing)Co., Ltd., Arthrex, Inc., STARmed Co., Ltd., AVNS, Olympus, BVM Medical Limited (RF Medical), Johnson & Johnson Services, Inc., Others
Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.”
Key Questions Answered in the Research Report:
What are the industry’s overall statistics or estimates (Overview, Size- By Value, Forecast Numbers, Segmentation, Shares)?
What are the trends influencing the current scenario of the market?
What key factors would propel and impede the industry across the country?
How has the industry been evolving in terms of geography & solution adoption?
How have buying behavior, customer inclination, and expectations from product manufacturers been evolving during 2024-30?
Who are the key competitors, and what strategic partnerships or ventures are they coming up with to stay afloat during the projected time frame?
Why MarkNtel Advisors?
MarkNtel Advisors is a leading research, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.
Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.
For Media Inquiries, Please Contact:
Email: [email protected]
Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511
Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301
0 notes
Text
Primary Sclerosing Cholangitis Market Size, Share and Future News by 2025-2033
The Reports and Insights, a leading market research company, has recently releases report titled “Primary Sclerosing Cholangitis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033.” The study provides a detailed analysis of the industry, including the global Primary Sclerosing Cholangitis Market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Report Highlights:
How big is the Primary Sclerosing Cholangitis Market?
The global primary sclerosing cholangitis market was valued at US$ 174.9 Million in 2024 and is expected to register a CAGR of 7.8% over the forecast period and reach US$ 370.8 Million in 2033.
What are Primary Sclerosing Cholangitis?
Primary sclerosing cholangitis (PSC) is a chronic liver condition characterized by ongoing inflammation and scarring of the bile ducts, leading to their narrowing, obstruction, and subsequent liver damage. Symptoms may include jaundice, itching, abdominal pain, and fatigue. PSC is often linked to an increased risk of liver cirrhosis and liver cancer. While the precise cause remains unclear, the disease is thought to involve autoimmune mechanisms and is frequently associated with inflammatory bowel diseases like ulcerative colitis. Treatment aims to alleviate symptoms, slow disease progression, and manage complications, with liver transplantation being a potential option for advanced stages.
Request for a sample copy with detail analysis: https://www.reportsandinsights.com/sample-request/2389
What are the growth prospects and trends in the Primary Sclerosing Cholangitis industry?
The primary sclerosing cholangitis (PSC) market growth is driven by various factors and trends. The market for primary sclerosing cholangitis (PSC) is expanding due to heightened awareness of the disease, improvements in diagnostic methods, and advancements in treatment options. Increasing recognition of PSC, particularly its links to inflammatory bowel diseases, along with the growing incidence of liver complications, is boosting demand for effective therapies. Key players in the market include pharmaceutical and biotechnology companies focusing on new drug developments and clinical trials. The market is also driven by the need for improved symptom management and potential curative approaches, such as liver transplantation. Despite challenges like high treatment costs and limited available therapies, ongoing research and innovation are contributing to the market's growth. Hence, all these factors contribute to primary sclerosing cholangitis (PSC) market growth.
What is included in market segmentation?
The report has segmented the market into the following categories:
By Type
Classic PSC
Variant PSC
PSC Associated with Autoimmune Hepatitis
PSC with Cholangiocarcinoma
By Treatment Type
Ursodeoxycholic Acid
Obeticholic Acid
Methotrexate
Corticosteroids
Others
By Route of Administration
Oral
Parental
Others
By End-User
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
North America
United States
Canada
Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Poland
Benelux
Nordic
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
ASEAN
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
Saudi Arabia
South Africa
United Arab Emirates
Israel
Rest of MEA
Who are the key players operating in the industry?
The report covers the major market players including:
Acorda Therapeutics, Inc.
Gilead Sciences, Inc.
NGM Biopharmaceuticals, Inc.
Intercept Pharmaceuticals, Inc.
Falk Pharma GmbH
Allergan Plc.
Shire Plc.
Durect Corporation
Conatus Pharmaceuticals, Inc.
Sirnaomics, Inc.
Shenzhen HighTide Biopharmaceutical Ltd.
Cymabay Therapeutics
Pliant Therapeutics
Immunic AG
View Full Report: https://www.reportsandinsights.com/report/Primary Sclerosing Cholangitis-market
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us:
Reports and Insights consistently mееt international benchmarks in the market research industry and maintain a kееn focus on providing only the highest quality of reports and analysis outlooks across markets, industries, domains, sectors, and verticals. We have bееn catering to varying market nееds and do not compromise on quality and research efforts in our objective to deliver only the very best to our clients globally.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact Us:
Reports and Insights Business Research Pvt. Ltd. 1820 Avenue M, Brooklyn, NY, 11230, United States Contact No: +1-(347)-748-1518 Email: [email protected] Website: https://www.reportsandinsights.com/ Follow us on LinkedIn: https://www.linkedin.com/company/report-and-insights/ Follow us on twitter: https://twitter.com/ReportsandInsi1
#Primary Sclerosing Cholangitis Market share#Primary Sclerosing Cholangitis Market size#Primary Sclerosing Cholangitis Market trends
0 notes
Text
According to report by IMARC Group provides the key factors driving the epidemiological trend of Cholangiocarcinoma.
0 notes
Link
0 notes
Text
Biliary Tract Cancers (BTCs)
Biliary tract cancers (BTCs), also referred to as cholangiocarcinomas, are uncommon and highly aggressive tumors that develop within the bile ducts—the network that transports bile from the liver to the gallbladder and small intestine. These malignancies can arise in different areas of the biliary tree, including intrahepatic, perihilar, and distal sections. Due to the absence of noticeable symptoms in early stages, BTCs are typically identified only after the disease has progressed, complicating treatment. Common signs of the disease include jaundice, unintentional weight loss, abdominal discomfort, and itching. Key risk factors include chronic liver conditions such as hepatitis, cirrhosis, and primary sclerosing cholangitis.
While treatment advancements—including surgery, chemotherapy, and targeted therapies—have been made, outcomes remain generally poor because of late diagnosis and limited effective options. BTCs predominantly affect people over the age of 50, with both genders impacted, and regional differences observed in incidence rates. Current research is centered on early diagnostic tools and more effective therapeutic approaches to improve patient survival.
Curious about the numbers? Dive into the data with our infographic
Epidemiological Segmentation (2020–2034)
Epidemiological analysis of BTC in the 7 major markets (7MM) is categorized into:
Total incident cases
Age-specific incidence
Stage-wise distribution
Tumor location-specific incidence
Mutation-specific cases
Number of treated cases
BTC Epidemiology (2023 Highlights)
In 2023, the U.S. contributed about 30% of all new BTC cases across the 7MM.
Within the U.S., TP53 mutation-positive BTC cases were the most common, followed by KRAS-positive cases.
Among EU4 and the UK, Italy recorded the highest number of BTC cases; Spain had the fewest.
In the U.S., the majority of cases occurred in individuals aged 70 to 79, comprising around 30% of all age-related cases.
BTC Market Overview
The market size for biliary tract cancers in the 7MM reached approximately USD 1 billion in 2023.
From insights to impact—read the full report now : Click Here
Market Growth Drivers
Increased focus on targeted therapy and immunotherapy research.
Rising number of clinical trials exploring novel BTC treatments.
Progress in diagnostic tools and biomarkers that enable earlier detection.
Boost in pharmaceutical investment in rare cancers and personalized medicine.
Market Challenges
Lack of effective, widely available targeted treatments.
Late detection contributes to limited treatment effectiveness and poorer outcomes.
High treatment costs, particularly for advanced therapies and surgeries.
Limited public and clinical awareness of BTC, resulting in delays in diagnosis and intervention.
One graphic, all the essentials— Click to explore
Promising Pipeline Therapies
Emerging drugs under development include:
Tinengotinib
Rilvegostomig
ENHERTU (trastuzumab deruxtecan)
LENVIMA (lenvatinib)
Tasurgratinib (by Eisai)
Silmitasertib (CX-4945)
Among others
Key Companies in the BTC Space
Major pharmaceutical and biotech firms involved in BTC drug development include:
Compass Therapeutics
Jazz Pharmaceuticals
Zymeworks
AstraZeneca
Daiichi Sankyo
Merck Sharp & Dohme
Eisai
Senhwa Biosciences
Seagen
Pfizer
TransThera Sciences
Compugen
Bold Therapeutics
And others
Numbers tell part of the story—get the full analysis in our report
0 notes
Text
Veterinary Services Strategies In The Global Market: Key Insights From The 2025 Report
The global Pancreatic And Biliary Stents Market was valued at USD 354.2 million in 2023 and is projected to reach USD 511.47 million by 2031, growing at a compound annual growth rate (CAGR) of 4.7% over the forecast period of 2024-2031. This growth is driven by the increasing prevalence of pancreatic and biliary diseases, advancements in stent technology, and the growing number of minimally invasive procedures globally.
Get Free Sample Report on Pancreatic and Biliary Stents Market
Pancreatic and biliary stents are medical devices that are used to treat various conditions of the pancreas and bile ducts, including chronic pancreatitis, bile duct obstruction, pancreatic cancer, and gallstones. These stents are inserted into the ducts to help maintain their patency, ensuring the normal flow of bile or pancreatic fluids. The increasing incidence of gastrointestinal disorders, such as pancreatitis and bile duct blockages, has significantly contributed to the demand for these devices.
Key Drivers of Market Growth
Increasing Prevalence of Pancreatic and Biliary Disorders: The global rise in pancreatic and biliary diseases, including conditions such as pancreatitis, cholangiocarcinoma (bile duct cancer), and pancreatic cancer, is one of the primary factors contributing to the growth of the pancreatic and biliary stents market. According to the World Health Organization (WHO), pancreatic cancer is one of the leading causes of cancer-related deaths worldwide. As these diseases continue to affect an increasing number of people, the demand for stents, particularly in the management of these conditions, is expected to rise significantly.
Rising Adoption of Minimally Invasive Procedures: Minimally invasive procedures, including the use of endoscopic techniques to insert pancreatic and biliary stents, are increasingly preferred due to their lower risks, shorter recovery times, and reduced discomfort for patients. The growing trend of performing complex gastrointestinal procedures with minimal incision and reduced risk of complications is driving the demand for pancreatic and biliary stents. These procedures help to address conditions such as obstructed bile ducts, improving patients' quality of life and reducing the need for traditional surgery.
Technological Advancements in Stent Designs: The development of advanced stent technologies, including drug-eluting stents (DES) and biodegradable stents, is another key factor contributing to the market's growth. Drug-eluting stents, which release medication over time to prevent stent occlusion and restenosis, are increasingly being used to improve treatment outcomes. Biodegradable stents, which dissolve naturally over time, are expected to gain popularity due to their ability to reduce the need for removal procedures. These advancements are expected to boost the effectiveness of treatments and improve patient outcomes, further driving the growth of the pancreatic and biliary stents market.
Growing Demand for Advanced Medical Treatments: As healthcare systems across the globe continue to improve, the demand for advanced medical treatments is on the rise. This includes the increased use of stents for the management of complex pancreatic and biliary conditions. Rising healthcare expenditures and the increasing availability of healthcare services in emerging economies are expected to drive the adoption of pancreatic and biliary stents in these regions, further expanding the market.
Aging Population: The aging global population is another important driver for the growth of the pancreatic and biliary stents market. Older individuals are more susceptible to pancreatic and biliary diseases due to factors such as weakened immune systems, chronic conditions, and lifestyle factors. As the population of elderly individuals continues to rise, the demand for medical devices like pancreatic and biliary stents to manage these conditions is expected to increase.
Improved Diagnosis and Awareness: As awareness of pancreatic and biliary diseases grows, more people are seeking medical attention and receiving early diagnoses. Improvements in diagnostic imaging and technologies, such as endoscopic retrograde cholangiopancreatography (ERCP), have enabled better detection of blockages, stenosis, and other conditions affecting the bile ducts and pancreas. This early detection allows for timely intervention and the increased use of stents to treat these conditions.
KEY MARKET SEGMENTATION
By Product Type
Metal Stents
Plastic Stents
By Applications
Bilio-pancreatic leakages
Pancreatic Cancer
Benign Biliary strictures
Others
By End Users
Hospitals
Ambulatory Surgical Centers
Speciality Clinics
Others
Make Enquiry about Pancreatic and Biliary Stents Market
Competitive Landscape
The pancreatic and biliary stents market is competitive, with several key players leading the industry. Prominent companies include Boston Scientific Corporation, Cook Medical, Medtronic, Abbott Laboratories, and Terumo Corporation. These companies are focused on product innovation, expanding their market presence, and forming strategic partnerships to maintain a competitive edge.
Boston Scientific Corporation: Boston Scientific offers a range of advanced pancreatic and biliary stents, including self-expanding metal stents and plastic stents, and is a leader in the market due to its continuous innovation and product development.
Cook Medical: Cook Medical is another major player in the pancreatic and biliary stents market, known for its high-quality stent offerings and its commitment to advancing minimally invasive treatments.
Medtronic: Medtronic is a leading global healthcare company that provides a wide range of stents for various applications, including pancreatic and biliary treatments. The company's strong presence in the global medical device market gives it a competitive edge.
Conclusion
The pancreatic and biliary stents market is expected to experience significant growth, driven by the increasing prevalence of pancreatic and biliary diseases, the growing demand for minimally invasive treatments, and advancements in stent technology. With a projected market value of USD 511.47 million by 2031, the market is set to benefit from innovations such as biodegradable stents, drug-eluting stents, and improvements in stent design. As the demand for advanced gastrointestinal treatments continues to rise, pancreatic and biliary stents will play a critical role in managing these complex conditions, improving patient outcomes, and contributing to the overall growth of the healthcare industry.
About US:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
Contact Us:
Jagney Dave - Vice President of Client Engagement
Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)
#Pancreatic and Biliary Stents Market#Pancreatic and Biliary Stents Market Size#Pancreatic and Biliary Stents Market Report#Pancreatic and Biliary Stents Market Trend#Pancreatic and Biliary Stents Market Share#Pancreatic and Biliary Stents Market Growth
0 notes
Text
The Cholangiocarcinoma Market in 2023 is US$ 236.82 million, and is expected to reach US$ 630.46 million by 2031 at a CAGR of 13.00%.
0 notes
Text
0 notes
Text
Holidays 2.15
Holidays
Angelman Syndrome Day
Annoy Squidward Day (SpongeBob Squarepants)
Battleship Day
Broken Hearts Day
Clifford the Big Red Dog Day
Commonwealth Day (Gibraltar)
Court of International Justice Day
Day of Ashakalia (Kosovo)
Day of the Mexican Woman (Mexico)
Decimal Day (UK)
Digital Learning Day
ENIAC Day (Philadelphia, Pennsylvania)
European Perioperative Nursing Day (EU)
First Connections Awareness Day (Rhode Island)
Galileo Day [also 2.29]
Hazel Day (French Republic)
Hazrat Alis Day (Uttar Pradesh, India)
International Angelman Day
International Bottom Appreciation Day
International Childhood Cancer Day
International Duties Memorial Day (Russia)
International Fanworks Day
International Green Wall Day
International Male Chastity Day
John Frum Day (Vanuatu)
Love Reset Day
Lui-Ngai-Ni (Manipur, India)
Memorial Day of Warriors—Intrnationalists
National Bad Breath Day
National Black Girl Magic Day
National Friendzone Day
National Plan B Day
National School Resource Officer Appreciation Day
National Side Chicks Day
National Wisconsin Day
Plastic Pollution Awareness Day (Georgia)
Remember the Maine Day
Sandlasting Day
Singles Awareness Day
Slap Day
Sretenje (Serbia)
Sticky Stamp Day
Stop and Smell Your Compost Pile Day
St. Skeletor’s Day
Susan B. Anthony Day
Total Defense Day (Singapore)
World Cholangiocarcinoma Day
YouTube Launch Day
Food & Drink Celebrations
Burger Lover's Day
Cherry Garcia Day
Florida Craft Beer Day
Mustard Day
National Cheap Chocolate Day
National Chewing Gum Day
National Gumdrop Day
National I Want Butterscotch Day
National Lamb Day (New Zealand)
Nature Celebrations
Cedar Day (I Live For You; Korean Birth Flowers)
World Hippo Day
Independence, Flag & Related Days
Barbettia (Declared; 2016) [unrecognized]
Dadingisila (Declared; 2010) [unrecognized]
Flag Day (Canada)
Liberation Day (Afghanistan)
Iustus (Declared; 2018) [unrecognized]
Serbia (from the Ottoman Empire, 1804)
St. Louis (Establishment Day; Missouri; 1764)
3rd Saturday in February
Barley Wine Day (San Francisco) [Saturday before Presidents Day]
Community Pubs Week begins (UK) [3rd Saturday through 4th Saturday]
International Restaurant Day [3rd Saturday] (also May, Aug & Nov)
National Black Movie Day [3rd Saturday]
Red Sock Day [3rd Saturday]
Sandwich Saturday [Every Saturday]
Sentimental Saturday [3rd Saturday of Each Month]
Six For Saturday [Every Saturday]
Spaghetti Saturday [Every Saturday]
Steak Saturday [3rd Saturday of Each Month]
World Pangolin Day [3rd Saturday]
World Whale Day [3rd Saturday]
Weekly Holidays beginning February 15 (2nd Week of February)
Hardee County Fair (Wauchula, Florida) [thru 2.22]
National FFA Week (thru 2.22) [Saturday to Saturday containing 2.22]
National Write Your Book in a Weekend Weekend
Omaha Beer Week (Omaha, Nebraska) [thru 2.23]
Real Bread Week (thru 2.23) [2nd to Last Saturday to Saturday]
Festivals On or Beginning February 15, 2025
Asian American Expo (La Verne, California) [thru 2.16]
Arizona Strong Beer Festival (Phoenix, Arizona)
Bay Area Renaissance Festival (Tampa, Florida) thru 3.30]
Bayou King Cake Festival (Thibodaux, Louisiana)
Carnival of Acireale (Acireale, Sicily, Italy) [thru 3.4]
Cedarburg Winter Festival (Cedarburg, Wisconsin) [thru 2.16]
Chinese New Year’s Parade (San Francisco, California)
Color the Wind Kite Festival (Clear Lake, Iowa)
Cortez Commercial Fishing Festival (Cortez, Florida) [thru 2.16]
Florida Keys Seafood Festival (Key West, Florida)) [thru 2.16]
International White Wine Festival in Anderson Valley (Boonville, California) [thru 2.16]
Jupiter Seafood Festival (Jupiter, Florida) [thru 2.16]
Melodifestivalen (Västeras, Sweden)
Menton Lemon Festival (Menton, France) [thru 3.2]
Nice Carnival (Nice, France) [thru 3.2]
NYS Ice Wine & Culinary Festival (Fairport, New York)
Palm Beach Marine Flea Market and Seafood Festival (West Palm Beach, Florida) [thru 2.16]
Takeuchi Festival (Rokugo, Japan)
Writers Guild Awards (Los Angeles, California)
3rd Thursday in February
Energy Saving Day (Italy) [3rd Thursday]
Global Information Governance Day [3rd Thursday]
National Conductive Education Day [3rd Thursday]
Switch Off Thursday (UK) [Thursday of Go Green Week]
Throwback Thursday [Every Thursday]
World Anthropology Day [3rd Thursday]
World Cholanglocarcinoma Day [3rd Thursday]
Weekly Holidays beginning February 15
American Association for the Advancement of Science Week [thru 2.17]
National Write Your Book in a Weekend Weekends [thru 2.18] (also in Apr, Sep & Nov)
Feast Days
Agape (Christian; Virgin Martyr)
Candlemas (Eastern Orthodox Church)
Chongwoldaeboreum (Korean Folk Festival)
Claude de la Colombière (Christian; Saint)
Drink More Wine Day (Pastafarian)
Faunus (celebrates animals helping humans)
Faustinus and Jovita (Christian; Martyrs)
Februata — Day of Juno Febuata (Pagan)
Festival of Naked Pan (Ancient Rome)
Festival of the Wolves (Starza Pagan Book of Days)
Grigori Rasputin Day (Church of the SubGenius)
Guardian Angel Day (Celtic Book of Days)
Kamakura Matsuri (Snow Cave Festival; Japan)
Lupercalia (Festival of Lupercus; Festival of purification honoring Lycaen Pan or Faunusl Ancient Roman god of flocks and fertility)
Michał Sopoćko (Christian; Blessed)
Nirvana Day (Buddhist; Jain; Sikh)
Oswiu (Christian; Saint)
Parinirvana Day (Mahayana Buddhism)
Phaedrus (Positivist; Saint)
Quinidius (Christian; Saint)
The Raggmopps (Muppetism)
Sarkis of Armenia (Christian; Saint)
Sigfried of Sweden (Christian; Saint)
Sigfrid’s Day
Tales of Kelp-Koli (Shamanism)
Tanco (a.k.a. Tatto; Christian; Martyr)
Thomas Bray (Anglican & Episcopal Church)
Walfrid (Christian; Saint)
Lunar Calendar Holidays
Chinese: Month 1 (Wu-Yin), Day 18 (Yi-Mao)
Day Pillar: Wood Rabbit
12-Day Officers/12 Gods: Remove Day (除 Chu) [Auspicious]
Holidays: None Known
Secular Saints Days
Susan B. Anthony (Politics)
Harold Arlen (Music)
John Barrymore (Entertainment)
Claire Bloom (Entertainment)
Norman Bridwell (Art)
Roger Chaffee (Astronaut)
Charles-François Daubigny (Art)
Galileo Galilei (Science)
Matt Groening (Art)
Douglas Hofstadter (Literature)
Harvey Korman (Entertainment)
Melissa Manchester (Music)
Sax Rohmer (Literature)
Jane Seymour (Entertainment)
Ernest Shackleton (Exploring)
Art Spiegelman (Art)
Charles-André van Loo (Art)
Alfred North Whitehead (Science)
Lucky & Unlucky Days
Shakku (赤口 Japan) [Bad luck all day, except at noon.]
Uncyclopedia Bad to Be Born Today (because so many reasons carrying on from the night before.)
Premieres
Alice’s Mysterious Mystery (Ub Iwerks Disney Cartoon; 1926)
Alice Solves the Puzzle (Ub Iwerks Disney Cartoon; 1925)
Alice’s Orphan (Disney Cartoon; 1930)
Angel and the Badman (Film; 1947)
Asterix: The Secret of the Magic Potion (Animated Film; 2019)
Autumn (Silly Symphony Disney Cartoon; 1930)
The Bears and the Bees (Disney Silly Symphony Cartoon; 1932)
The Blue Danube, by Johann Strauss II (Waltz; 1867)
The Breakfast Club (Film; 1985)
Blue Moon, recorded by The Marcels (Song; 1961)
Broad City (TV Series; 2010)
Bugs Bunny’s Wild World of Sports (WB Animated TV Special; 1989)
Burn, by Deep Purple (Album; 1974)
Burr Gore, by Vidal (Historical Novel; 1973)
Cinderella (Animated Disney Cartoon; 1950)
Clifford the Big Red Dog, by Norman Bridwell (Children’s Book; 1963)
Corregidora, by Gayl Jones (Novel; 1975)
Cowboy Blues (Aesop’s Sound Fable Cartoon; 1931)
The Crackpot Quail (WB MM Cartoon; 1941)
The Crystal Maze (UK TV game Show; 1990)
The Deep Boo Sea (Caspar Cartoon; 1952)
Doom Patrol (TV Series; 2019)
Eastbound & Down (TV Series; 2009)
Eight Days a Week, by The Beatles (Song; 1965)
Elegy Written in. A Country Churchyard, by Thomas Gray (Poem; 1751)
11.23.63 (TV Series; 2016)
Escape from Planet Earth (Animated Film; 2013)
Felix Crosses the Crooks (Felix the Cat Cartoon; 1927)
Felix the Cat Rests in Peace (Felix the Cat Cartoon; 1926)
Fly by Night, by Rush (Album; 1975)
Flying Yeast (Krazy Kat Cartoon; 1929)
Fun, Fun, Fun, by The Beach Boys (Song; 1964)
The Gay Anties (WB MM Cartoon; 1947)
Get Happy!!, by Elvis Costello (Album; 1980)
Glad All Over, by the Dave Clark Five (Song; 1964)
The Haunted Mouse (WB MM Cartoon; 1941)
The Heritage (Hearst-Pathe News Cartoon; 1918)
A Horse’s Tale (Sugarfoott Walter Lantz Cartoon; 1954)
Lifehouse, by The Who (Rock Opera; 1971)
Marlowe (Film; 2023)
Mechanical Man (Oswald the Lucky Rabbit Cartoon; 1932)
Orphan’s Picnic (Mickey Mouse Disney Cartoon; 1936)
Presidential One-Dollar Coin (U.S. Mint; 2007)
Professor Dabbler (Kriterion Kosmos Kartoons Cartoon; 1915)
Radio Riot (Fleischer Tarlkartoon Cartoon; 1930)
Red Dwarf (UK TV Series; 1988)
Return to Never Land (Disney Film; 2002)
Robin Hoody Woody (Woody Woodpecker Cartoon; 1963)
The Screwball (Woody Woodpecker Cartoon; 1943)
Shake, Rattle and Roll, recorded by Big Joe Turner (Song; 1954)
The Stars, Like Dust, byIsaac Asimov (Novel; 1951) [Galactic Empire #1]
Sucker Games (Krazy Kat Cartoon; 1926)
Super Troopers (Film; 2002)
Take the A Train, recorded by Duke Ellington (Song; 1941)
Taking the Blame (Betty Boop Cartoon; 1935)
A Tuba to Cuba (Documentary Film; 2019)
The Umbrella Academy (TV Series; 2019)
University of Nebraska (School; 1869)
Vision Quit (Film; 1985)
YouTube (Video Sharing Website; 2005)
Today’s Name Days
Georgia, Siegfried (Austria)
Faustin, Onezim, Vitomir (Croatia)
Jiřina (Czech Republic)
Faustinus (Denmark)
Neidi, Tiina (Estonia)
Sipi, Sippo (Finland)
Claude, Georgina, Jordan (France)
Georgia, Jovita, Siegfried (Germany)
Evsevios (Greece)
Julianna, Lilla (Hungary)
Giuliana (Italy)
Džuljeta, Juliāna, Jūlija, Smuidra (Latvia)
Julijona, Julijonas, Tautvydas (Lithuania)
Jill, Julian, Juliane (Norway)
Bernard, Dan, Danisz, Danuta, Julianna, Symeon (Poland)
Pamfil, Valentin (Romania)
Anna (Russia)
Ida (Slovakia)
Juliana (Spain)
Julia, Julius (Sweden)
Cliff, Clifford, Clifton, Jeremiah, Jeremy, Sonnie, Sonny, Sunny (USA)
Today’s National Name Days
National Clementine Day
National Marcus Day
Today is Also…
Day of Year: Day 46 of 2025; 319 days remaining in the year
ISO Week: Day 6 of Week 7 of 2025
Celtic Tree Calendar: Luis (Rowan) [Day 26 of 28]
Chinese: Month 1 (Wu-Yin), Day 18 (Yi-Mao)
Chinese Year of the: Snake 4723 (until February 17, 2026) [Ding-Chou]
Coptic: 8 Amshir 1741
Druid Tree Calendar: Hackberry (Feb 9-18) [Day 7 of 10]
Hebrew: 17 Shevat 5785
Islamic: 16 Sha’ban 1446
Julian: 2 February 2025
Moon: 91%: Waning Gibbous
Positivist: 18 Homer (2nd Month) [Phaedrus)
Runic Half Month: Sigel (Sun) [Day 10 of 15]
Season: Winter (Day 57 of 90)
SUn Calendar: 16 Gray; Twosday [16 of 30]
Week: 2nd Week of February
Zodiac:
Tropical (Typical) Zodiac: Aquarius (Day 27 of 30)
Sidereal Zodiac: Aquarius (Day 3 of 30)
Schmidt Zodiac: Capricorn (Day 21 of 27)
IAU Boundaries (Current) Zodiac: Capricorn (Day 27 of 28)
IAU Boundaries (1977) Zodiac: Capricornus (Day 28 of 28)
0 notes
Link
0 notes
Text
Primary Sclerosing Cholangitis Market Size, Share and Future News by 2025-2033
The Reports and Insights, a leading market research company, has recently releases report titled “Primary Sclerosing Cholangitis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033.” The study provides a detailed analysis of the industry, including the global Primary Sclerosing Cholangitis Market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Report Highlights:
How big is the Primary Sclerosing Cholangitis Market?
The global primary sclerosing cholangitis market was valued at US$ 174.9 Million in 2024 and is expected to register a CAGR of 7.8% over the forecast period and reach US$ 370.8 Million in 2033.
What are Primary Sclerosing Cholangitis?
Primary sclerosing cholangitis (PSC) is a chronic liver condition characterized by ongoing inflammation and scarring of the bile ducts, leading to their narrowing, obstruction, and subsequent liver damage. Symptoms may include jaundice, itching, abdominal pain, and fatigue. PSC is often linked to an increased risk of liver cirrhosis and liver cancer. While the precise cause remains unclear, the disease is thought to involve autoimmune mechanisms and is frequently associated with inflammatory bowel diseases like ulcerative colitis. Treatment aims to alleviate symptoms, slow disease progression, and manage complications, with liver transplantation being a potential option for advanced stages.
Request for a sample copy with detail analysis: https://www.reportsandinsights.com/sample-request/2389
What are the growth prospects and trends in the Primary Sclerosing Cholangitis industry?
The primary sclerosing cholangitis (PSC) market growth is driven by various factors and trends. The market for primary sclerosing cholangitis (PSC) is expanding due to heightened awareness of the disease, improvements in diagnostic methods, and advancements in treatment options. Increasing recognition of PSC, particularly its links to inflammatory bowel diseases, along with the growing incidence of liver complications, is boosting demand for effective therapies. Key players in the market include pharmaceutical and biotechnology companies focusing on new drug developments and clinical trials. The market is also driven by the need for improved symptom management and potential curative approaches, such as liver transplantation. Despite challenges like high treatment costs and limited available therapies, ongoing research and innovation are contributing to the market's growth. Hence, all these factors contribute to primary sclerosing cholangitis (PSC) market growth.
What is included in market segmentation?
The report has segmented the market into the following categories:
By Type
Classic PSC
Variant PSC
PSC Associated with Autoimmune Hepatitis
PSC with Cholangiocarcinoma
By Treatment Type
Ursodeoxycholic Acid
Obeticholic Acid
Methotrexate
Corticosteroids
Others
By Route of Administration
Oral
Parental
Others
By End-User
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
North America
United States
Canada
Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Poland
Benelux
Nordic
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
ASEAN
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
Saudi Arabia
South Africa
United Arab Emirates
Israel
Rest of MEA
Who are the key players operating in the industry?
The report covers the major market players including:
Acorda Therapeutics, Inc.
Gilead Sciences, Inc.
NGM Biopharmaceuticals, Inc.
Intercept Pharmaceuticals, Inc.
Falk Pharma GmbH
Allergan Plc.
Shire Plc.
Durect Corporation
Conatus Pharmaceuticals, Inc.
Sirnaomics, Inc.
Shenzhen HighTide Biopharmaceutical Ltd.
Cymabay Therapeutics
Pliant Therapeutics
Immunic AG
View Full Report: https://www.reportsandinsights.com/report/Primary Sclerosing Cholangitis-market
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us:
Reports and Insights consistently mееt international benchmarks in the market research industry and maintain a kееn focus on providing only the highest quality of reports and analysis outlooks across markets, industries, domains, sectors, and verticals. We have bееn catering to varying market nееds and do not compromise on quality and research efforts in our objective to deliver only the very best to our clients globally.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact Us:
Reports and Insights Business Research Pvt. Ltd. 1820 Avenue M, Brooklyn, NY, 11230, United States Contact No: +1-(347)-748-1518 Email: [email protected] Website: https://www.reportsandinsights.com/ Follow us on LinkedIn: https://www.linkedin.com/company/report-and-insights/ Follow us on twitter: https://twitter.com/ReportsandInsi1
#Primary Sclerosing Cholangitis Market share#Primary Sclerosing Cholangitis Market size#Primary Sclerosing Cholangitis Market trends
0 notes